Generic name |
codeine controlled release |
---|---|
Strength |
50 mg, 100 mg, 150 mg, 200 mg |
Form |
tablet |
Special Authority criteria |
Approval period |
---|---|
1. Diagnosis of cancer PLUS Patients who are unable to tolerate or receive an adequate response to the regular dosage forms of codeine |
First approval: 1 year Renewals: 1 year |
OR | |
2. Pain management in a specified chronic pain diagnosis* PLUS Patients who are unable to tolerate or receive an adequate response to the regular dosage forms of codeine |
First approval: 1 year Renewals: 1 year |